JEFFREY J. KIMBELL & ASSOCIATES, INC.

Lobbying for NEUROTECH PHARMACEUTICALS · pharmaceuticals

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · Rhode Island · House · Senate · $10,000.00 income · posted Apr 20, 2026

Lobbying activity 1

Health Issues

Issues related to approval of combination products

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem